Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Moumita Chatterjee

2PUBLICATIONS

4CO-AUTHORS

Rheumatology and arthritis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Nov 18, 2024

Defining Objective BASDAI Cut-Offs for Disease Activity States and Improvement Scores in Axial Spondyloarthritis: A Multicentric Collaboration.

Rudra Prosad Goswami, Moumita Chatterjee, Shyamashis Das

|Mar 21, 2024

Comparative Effectiveness of Tofacitinib and Adalimumab in Axial Spondyloarthritis: A Real-World Clinical Context Multicenter Study.

Rudra Prosad Goswami, Debanjali Sinha, Moumita Chatterjee

Pageof 1

Frequent Collaborators

2 joint publications

Rudra Prosad Goswami

2 joint publications

Shyamashis Das

1 joint publications

Debanjali Sinha

1 joint publications

Danveer Bhadu

Frequent Collaborators

2 joint publications

Rudra Prosad Goswami

2 joint publications

Shyamashis Das

1 joint publications

Debanjali Sinha

1 joint publications

Danveer Bhadu

Top Related Videos

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos

Top Related Videos

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on : Mar 01, 2024

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos